Author:
Quiroga Borja,Soler María José,Ortiz Alberto,Orero Esther,Tejedor Sandra,Mantecón Carlos Jesús Jarava,Gómez Pérez Virginia Olinda,Marín Franco Antonio José,Alfaro Sánchez Christian,Puerta Carretero Marta,Jaldo Rodríguez María Teresa,Carnerero Di Riso Manuel Antonio,Martínez Shaira,González Carmen Calderón,Cervienka Michal,Macías Carmona Nicolás,Arroyo David,Pérez del Valle Katia M.,de Arriba Gabriel,Mazuecos Auxiliadora,Cazorla Juan Manuel,Pereira Mónica,González Parra Emilio,Sánchez Márquez María Gabriela,Lancho Novillo Carolina,Toyos Ruiz Carmen,Aguilar Cervera María Cinta,Muñoz Ramos Patricia,Sánchez Horrillo Ana,Jimeno Martín Isabel,Toapanta Néstor,Cigarrán Guldris Secundino,Folgueiras López Montserrat,Valero San Cecilio Rosalía,Villacorta Linaza Blanca,Minguela Pesquera Ignacio,Santana Estupiñán Raquel,Zamora Rocío,Soriano Sagrario,Muñoz de Bustillo Eduardo,Pizarro Sánchez María Soledad,Martínez Puerto Ana Isabel,Yugueros Alejandra,Muñiz Pacios Laura,Leyva Alba,Rojas José,Gansevoort Ron T.,de Sequera Patricia
Funder
Vircell
Fresenius Medical Care
Vifor Pharma
Diaverum
Fundación Renal Iñigo Álvarez de Toledo
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology
Reference4 articles.
1. Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients: A randomized clinical trial;Reindl-Schwaighofer;JAMA Intern Med,2022
2. Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: The SENCOVAC study;Quiroga;Nephrol Dial Transplant
3. Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: The multicentric SENCOVAC study;Quiroga;Nephrol Dial Transplant
4. A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis;Espi;Kidney Int,2022